MEDPACTO, INC.

City:

Seoul

Country:

South Korea

Published Applications:

Last publication date:

2024-07-11

Patent Grants:

Last grant date:

2024-06-11

Top Inventors for applications by MEDPACTO, INC.

These are the the leading inventors for applications assigned to MEDPACTO, INC.:

Seong Jin KIM 5 Seoul, South Korea
Su-Jin Park 2 Gyeonggi-do, South Korea
Eun Ji Hong 2 Seoul, South Korea
Jin Sun HEO 2 Gyeonggi-do, South Korea

Min Woo KIM 2 Seoul, South Korea
Hae In AN 2 Gyeonggi-do, South Korea
Dong Woo KANG 2 Seoul, South Korea
Seung Ho Lee 1 Seoul, South Korea

Joon JEONG 1 Seoul, South Korea
Kyung Min YANG 1 Incheon, South Korea
Sung Gwe AHN 1 Seoul, South Korea
Chan-young OCK 1 Seoul, South Korea

Seok Hee Park 1 Suwon, Gyeonggi-do, South Korea
Seok Hee Park 1 Gyeonggi-do, South Korea

Recent patent applications by MEDPACTO, INC.

MEDPACTO, INC. based in Seoul, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-07-11

US20240228582A9

Chemistry; metallurgy

TM4SF19 INHIBITOR AND USES THEREOF

#2 | 2024-04-25

US20240132571A1

Chemistry; metallurgy

TM4SF19 INHIBITOR AND USES THEREOF

#3 | 2023-09-28 ✅ Patent 12,006,315 granted on 2024-06-11

US20230303568A1

Chemistry; metallurgy

Intermediate useful for the synthesis of TGF-beta inhibitors and a method of preparing TGF-beta inhibitors using the same

#4 | 2023-06-22 ✅ Patent 12,583,915 granted on 2026-03-24

US20230194534A1

Physics

METHODS FOR DIAGNOSING CANCER USING ANTI-BAG2 ANTIBODY

#5 | 2023-06-15 ✅ Patent 12,122,822 granted on 2024-10-22

US20230183324A1

Chemistry; metallurgy

Anti-BAG2 antibody and methods of treating cancer

#6 | 2021-08-05

US20210238698A1

Chemistry; metallurgy

METHODS OF DIAGNOSING AND TREATING CANCER PATIENTS EXPRESSING HIGH LEVELS OF TGF-B RESPONSE SIGNATURE

Also check out MedPacto Inc.'s (Seoul, South Korea) applicant profile with 5 patent applications submitted.

AssigneeID:

313582 ⎘